SCHEMBL1699014

SCHEMBL1699014

c1cc(N[C@@H]2CCCC[C@H]2Nc2ccc3ccccc3n2)nc(-c2c3ccccc3cc3ccccc23)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HCRTR1 O43613 4/20 0.40
HCRTR2 O43614 4/20 0.40
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NCF1 P14598 1/20 0.38
IRAK4 Q9NWZ3 2/20 0.37
MCHR1 Q99705 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
USP30 Q70CQ3 1/20 0.34
MAPK8 P45983 1/20 0.34
MAPK9 P45984 1/20 0.34
NPY5R Q15761 1/20 0.34
SSTR3 P32745 1/20 0.34
OGG1 O15527 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1708938 1.00 NPC1 (0.42) NPC1RAB9AHCRTR1HCRTR2DDB1
SCHEMBL1708932 0.81 NPC1 (0.58) NPC1RAB9AHCRTR1HCRTR2DDB1
SCHEMBL1699050 0.81 NPC1 (0.58) NPC1RAB9AHCRTR1HCRTR2DDB1
SCHEMBL16666168 0.71 NPC1 (0.56) NPC1RAB9ADDB1CRBNKDM4E
SCHEMBL9056686 0.70 NPC1 (0.59) NPC1RAB9ADDB1CRBNKDM4E
Hydrochloric Acid SCHEMBL8852766 0.68 NPC1 (0.57) NPC1RAB9ADDB1CRBNKDM4E
SCHEMBL24092000 0.68 MCHR1 (0.57) NPC1RAB9AHCRTR1HCRTR2DDB1
SCHEMBL29911218 0.68 MCHR1 (0.57) NPC1RAB9AHCRTR1HCRTR2DDB1
SCHEMBL31620776 0.67 NCF1 (0.57) NPC1RAB9ADDB1CRBNKDM4E
Hydrochloric Acid SCHEMBL6831814 0.67 L3MBTL1 (0.54) NPC1RAB9AHCRTR1HCRTR2MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889863-B2 Stereoselective methods, catalysts and intermediates for the synthesis of (−)-Nutlin-3 and related compounds VANDERBILT UNIVERSITY (US) 2014-11-18 US disclosed
US-8889863-B2 Stereoselective methods, catalysts and intermediates for the synthesis of (−)-Nutlin-3 and related compounds VANDERBILT UNIVERSITY (US) 2014-11-18 US disclosed
US-20120088915-A1 STEREOSELECTIVE METHODS, CATALYSTS AND INTERMEDIATES FOR THE SYNTHESIS OF (-)-NUTLIN-3 AND RELATED COMPOUNDS VANDERBILT UNIVERSITY 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088915-A1 STEREOSELECTIVE METHODS, CATALYSTS AND INTERMEDIATES FOR THE SYNTHESIS OF (-)-NUTLIN-3 AND RELATED COMPOUNDS NUTF2, MDM2, CIAPIN1 NPC1 2645/4885RAB9A 3389/4885HCRTR1 4766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.